Literature DB >> 19109351

Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry.

Masoud Shafazand1, Maria Schaufelberger, Georgios Lappas, Karl Swedberg, Annika Rosengren.   

Abstract

AIMS: To investigate gender-specific trends in long-term mortality in patients hospitalized for heart failure (HF). METHODS AND
RESULTS: The Swedish hospital discharge and cause-specific death registers were used to calculate age- and gender-specific trends for long-term prognosis in patients hospitalized with a principal diagnosis of HF from 1987 to 2003. Mortality decreased, mainly during 1987-95, with no further decrease after 2001. Survival in men improved more than in women (P-value for interaction 0.0003), particularly among patients aged <65 years (P-value for interaction: age, gender, and year of hospitalization 0.0003) and more for patients with ischaemic when compared with non-ischaemic HF (P-value for interaction <0.0001). Among men <65 years, the hazard ratio (HR) of dying within 3 years after discharge was 0.40 (95% confidence interval 0.36-0.45) during 1999-2001 when compared with 1987-89. The corresponding HR for women was 0.58 (0.48-0.69). For those discharged during 1999-2001, almost 20% of the patients aged 35-64 years and 40% of those aged 65-84 years died within 3 years.
CONCLUSION: Long-term mortality in HF in Sweden decreased more for men than for women and more for ischaemic than non-ischaemic HF. There was no further decrease after 2001. Long-term mortality after a first hospitalization remained high.

Entities:  

Mesh:

Year:  2008        PMID: 19109351     DOI: 10.1093/eurheartj/ehn541

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  28 in total

1.  Long-term effects of a dyadic psycho-educational intervention on caregiver burden and morbidity in partners of patients with heart failure: a randomized controlled trial.

Authors:  Maria Liljeroos; Susanna Ågren; Tiny Jaarsma; Kristofer Årestedt; Anna Strömberg
Journal:  Qual Life Res       Date:  2016-09-08       Impact factor: 4.147

2.  Improved outcome with repeated intracoronary injection of bone marrow-derived cells within a registry: rationale for the randomized outcome trial REPEAT.

Authors:  Birgit Assmus; Samer Alakmeh; Salvatore De Rosa; Halvard Bönig; Eva Hermann; Wayne C Levy; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Eur Heart J       Date:  2015-10-29       Impact factor: 29.983

3.  Long-term assessment of nocturnal Cheyne-Stokes respiration in patients with heart failure.

Authors:  Offer Amir; Deganit Barak-Shinar; Rafael Wolff; Hagar Paz; Guy Dori; Frank W Smart; Basil S Lewis
Journal:  Sleep Breath       Date:  2010-12-02       Impact factor: 2.816

Review 4.  Self care in patients with chronic heart failure.

Authors:  Barbara Riegel; Christopher S Lee; Victoria Vaughan Dickson
Journal:  Nat Rev Cardiol       Date:  2011-07-19       Impact factor: 32.419

5.  Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Authors:  Linda B Piller; Sarah Baraniuk; Lara M Simpson; William C Cushman; Barry M Massie; Paula T Einhorn; Suzanne Oparil; Charles E Ford; James F Graumlich; Richard A Dart; David C Parish; Tamrat M Retta; Aloysius B Cuyjet; Syed Z Jafri; Curt D Furberg; Mohammad G Saklayen; Udho Thadani; Jeffrey L Probstfield; Barry R Davis
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

6.  The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.

Authors:  M Lind; M Olsson; A Rosengren; A-M Svensson; I Bounias; S Gudbjörnsdottir
Journal:  Diabetologia       Date:  2012-08-16       Impact factor: 10.122

7.  Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation--results for Canada, Italy, Sweden and Switzerland.

Authors:  Jonas Nilsson; Örjan Åkerborg; Gaëlle Bégo-Le Bagousse; Mårten Rosenquist; Peter Lindgren
Journal:  Eur J Health Econ       Date:  2012-05-03

8.  The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation.

Authors:  Per Wändell; Axel C Carlsson; Martin J Holzmann; Johan Ärnlöv; Jan Sundquist; Kristina Sundquist
Journal:  J Cardiol       Date:  2018-02-01       Impact factor: 3.159

9.  Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure).

Authors:  Mark C Petrie; Pardeep S Jhund; Lilin She; Christopher Adlbrecht; Torsten Doenst; Julio A Panza; James A Hill; Kerry L Lee; Jean L Rouleau; David L Prior; Imtiaz S Ali; Jyotsna Maddury; Krzysztof S Golba; Harvey D White; Peter Carson; Lukasz Chrzanowski; Alexander Romanov; Alan B Miller; Eric J Velazquez
Journal:  Circulation       Date:  2016-08-29       Impact factor: 29.690

10.  The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure.

Authors:  Serkan Ozturk; Selçuk Öztürk; Fatma Hizal Erdem; Alim Erdem; Selim Ayhan; İbrahim Dönmez; Mehmet Yazıcı
Journal:  J Interv Card Electrophysiol       Date:  2016-04-02       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.